Investor's Watch Todays List (APRI, FB, APOL, TWI)

New York City, NY -- (SBWIRE) -- 06/10/2013 -- Apricus Biosciences, Inc. (NASDAQ:APRI) Apricus Biosciences, which concentrates on developing drugs in the area of libido, said its Vitaros drug for hard to treat cases of male impotence was accepted by Western authorities. Stocks increased 11% to $2.84 premarket. that help huge individual communities across numerous, large-market healing sessions such as men and women libido. The Company has one accepted product, Vitaros(R), for the treatment of male impotence, which is now accepted in Western countries and North america.